Rare diseases
Investigational molecules
Locations
A study to evaluate the safety and tolerability of tinlarebant in patients with Stargardt disease
BelgiumA study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.
BelgiumA study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis
BelgiumA study to evaluate the effect of valproic acid in women of reproductive age with adenomyosis
BulgariaStudy of ASP-1929 and pembrolizumab for patients with recurrent head and neck squamous cell carcinoma without distant metastases
PolandA study to evaluate the safety and effectiveness of ANXV in patients with diabetic retinopathy or retinal vein occlusion
GermanyA study of tirzepatide and levonorgestrel in women with endometrial cancer
Ireland
ItalyStudy of the efficacy and safety of Eloralintide in adults with knee osteoarthritis and overweight or obesity
BelgiumA study to evaluate the safety and effectiveness of surlorian in adults with RYR1-related myopathy
FranceA study to evaluate the use of levothyroxine sodium in patients with sudden onset of dizziness caused by inner ear issues.
GermanyStudy of pembrolizumab, capecitabine, or olaparib in patients with early-stage triple negative breast cancer and remaining disease after initial treatment
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
